ASN Neuro · Nov 14, 2026
Emerging Insights into Autophagy–Lysosomal Dysfunction in Age-Related Neurodegenerative Disorders
By Basha S, Chattopadhyay A, Pai AR et al.
Ageing is associated with changes in autophagic–lysosomal quality control, but these changes are not uniform and do not necessarily indicate reduced autophagy. This narrative review uses a clearance-bottleneck framework to examine how defects in pathway capacity, cargo recognition, autophagosome formation, trafficking, or lysosomal degradation may affect the ageing nervous system. It integrates evidence on lysosomal function and biogenesis, nutrient-sensing and transcriptional regulation, macroautophagy, chaperone-mediated autophagy, protein turnover, and organelle quality control. The review considers how these processes intersect with protein aggregation, mitochondrial dysfunction, synaptic regulation, and inflammatory communication among neurons, microglia, and astrocytes. Findings across Alzheimer’s disease and tauopathies, Parkinson’s disease, amyotrophic lateral sclerosis/frontotemporal dementia, and Huntington’s disease/polyglutamine disorders are compared with attention to cargo, cellular context, model, and evidence from human studies. Methodological limitations are emphasized, particularly the inability of autophagy markers alone to establish completed flux. Therapeutic studies are evaluated separately for rescue, human target engagement, and clinical benefit. Evidence does not establish that precision correction of a defined neuronal autophagy defect improves clinical outcomes. The framework identifies priorities for validating clearance defects and testing interventions.
doi.org/10.1080/17590914.2026.2759459Open accessPubMed 43033473Mechanisms